October 3, 2019

CSACI position statement: Newer generation H1-antihistamines are safer than first-generation H1-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria

  • Review
  • Open Access

Article metrics


Abstract
Oral H1-antihistamines (AHs) are the most commonly used therapy to treat allergic rhinitis and chronic urticaria. Older, first-generation AHs (e.g. diphenhydramine, hydroxyzine) have significant and common side effects including sedation, impairment with decreased cognitive function, poor sleep quality, dry mouth, dizziness, and orthostatic hypotension. These drugs have also been found to result in death from accidents, intentional or unintentional overdoses, and sudden cardiac death.

Indoor exposure to particulate matter and volatile organic compounds in dwellings and workplaces and respiratory health in French farmers

  • Original research article
  • Open Access

Abstract
Introduction
Few investigations have related objective assessments of indoor air pollutants to respiratory health in farmers, in spite of the many rural environmental hazards to which they are exposed. Chemical air pollution has been particularly neglected.

October 2, 2019

Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications



Abstract: Chronic urticaria (CU) is a mast cell-driven disease characterized by the development of wheals, angioedema, or both for more than 6 weeks. The two major sub-types are chronic spontaneous urticaria (CSU) and inducible urticaria. In the last decade different pathophysiological mechanisms, potentially responsible for the development of the disease, have been described.

September 28, 2019

Engaging and Educating Patients to Improve AD Care: A Practical Toolkit for Clinical Teams

Intended Audience: Physicians, Nurse Practitioners, Physician Assistants, and Nurses
Did you know that patients who learn about their own health conditions and partner with their clinical teams to decide on the best treatments are much happier and achieve better outcomes with their care?

This inclusive guide provides clinicians with materials and resources to engage and educate patients, individually or through group education, about atopic dermatitis (AD) and help build a strong foundation for informed decision-making regarding treatment goals, preferences, and plans.
Included in this guide:

September 27, 2019

The Skin in Celiac Disease Patients: The Other Side of the Coin

Medicina 201955(9), 578; https://doi.org/10.3390/medicina55090578
Review

Abstract

: 
Celiac disease (CD) is an autoimmune enteropathy that primarily affects the small intestine and is characterized by atrophy of intestinal villi. The manifestations of the disease improve following a gluten-free diet (GFD). CD is associated with various extra-intestinal diseases. Several skin manifestations are described in CD patients. The present paper reviews all CD-associated skin diseases reported in the literature and tries to analyze the pathogenic mechanisms possibly involved in these associations.

September 26, 2019

Is chronic urticaria more than skin deep?


volume
 


Abstract
Involved systems in chronic urticaria and relevant manifestations
Chronic urticaria is a disease characterized by the appearance of weals, angioedema or both longer than 6 weeks. Degranulation of cutaneous or submucosal mast cells leads to release of mediators including histamine resulting in redness, swelling and itch. Because mast cells are widely distributed throughout the body, the question is why they are not activated systemically or does systemic activation occur without overt end organ dysfunction?

September 25, 2019

Oral immunotherapy with peach juice in patients allergic to LTPs

  • Short report
  • Open Access


Abstract
Introduction
To assess the safety and efficacy of an oral immunotherapy regimen in patients with allergy to lipid transfer proteins (LTPs).
Materials and methods
Prospective study of 24 patients allergic to LTP with positive skin test and a history of anaphylaxis. All patients underwent a desensitization protocol with commercial peach juice. Rising doses of peach juice were administered, starting with an initial dose of seven drops of a 1/1000 dilution and finishing with a dose of 5 ml at visit 17.

WORLD LUNG DAY 2019: HEALTHY LUNGS FOR ALL



World Lung Day (WLD), 25 September, is a day for lung health advocacy and action, an opportunity for us all to unite and promote better lung health globally.
If you haven’t joined yet, sign up as a WLD partner by emailing lisa.roscoe@firsnet.org, all our WLD partners are included on our partners page
Respiratory diseases impose an immense worldwide health burden. The facts are shocking:
  • 65 million people suffer from chronic obstructive pulmonary disease (COPD) and 3 million die from it each year, making it the third leading cause of death worldwide.
  • 10 million people develop tuberculosis and 1.6 million die from it each year, making it the most common lethal infectious disease.

September 24, 2019

High oral corticosteroid exposure and overuse of short-acting beta-2-agonists were associated with insufficient prescribing of controller medication: a nationwide electronic prescribing and dispensing database analysis

  • Research
  • Open Access
Background
Recurrent use of oral corticosteroids (OCS) and over-use of short-acting beta-2-agonists (SABA) are factors associated with adverse side effects and asthma-related death. We aim to quantify high OCS exposure, SABA over-use and its association with prescription and adherence to maintenance treatment for respiratory disease, among patients with prescriptions for respiratory disease, from the Portuguese electronic prescription and dispensing database (BDNP).
Methods
This was a 1-year (2016) retrospective population-based analysis of a random sample of adult patients from the BDNP, the nationwide compulsory medication prescription system. We assessed high OCS exposure (dispensing ≥ 4 packages containing 20 doses of 20 mg each of prednisolone-equivalent, ≥ 1600 mg/year) on patients on persistent respiratory treatment (PRT-prescription for > 2 packages of any respiratory maintenance medications). Excessive use of SABA was defined as having a ratio of SABA-to-maintenance treatment > 1 or having SABA over-use (dispensing of > 1 × 200 dose canister/month, of 100 μg of salbutamol-equivalent). Factors associated with high OCS exposure were assessed by multinomial logistic regression.
Results
Frequency (%) of SABA users and OCS users on persistent respiratory treatment,
by primary adherence to controller medication and ratio maintenance-to-total
The estimated number of patients on PRT was 4786/100,000 patients. OCS was prescribed to more than 1/5 of the patients on PRT and 101/100,000 were exposed to a high-dose (≥ 1600 mg/year). SABA excessive use was found in 144/100,000 patients and SABA over-use in 24/100,000. About 1/6 of SABA over-users were not prescribed any controller medication and 7% of them had a ratio maintenance-to-total ≥ 70% (high prescription of maintenance treatment). Primary adherence (median%) to controller medication was 66.7% for PRT patients, 59.6% for patients exposed to high OCS dose and 75.0% for SABA over-users. High OCS exposure or SABA over-use were not associated with primary adherence. High OCS exposure was associated with a maintenance-to-total medication ratio < 70% (insufficient prescription of maintenance treatment), age > 45 years old and male sex.
Conclusions
Exposure to high-dose of OCS (101 per 100,000 patients) and SABA over-use (24 per 100,000) were frequent, and were associated with a low maintenance-to-total prescription ratio but not with primary non-adherence. These results suggest there is a need for initiatives to reduce OCS and SABA inappropriate prescribing.

September 21, 2019

Management of chronic urticaria in children: a clinical guideline


Italian Journal of Pediatrics December 2019, 45:101
Authors and affiliations

Carlo Caffarelli, Francesco Paravati, Maya El Hachem, Marzia Duse, Marcello Bergamini, Giovanni Simeone, Massimo Barbagallo, Roberto Bernardini, Paolo Bottau, Filomena Bugliaro, Silvia Caimmi, Fernanda Chiera, Giuseppe Crisafulli, Cristiana De Ranieri, Dora Di Mauro, Andrea Diociaiuti, Fabrizio Franceschini, Massimo Gola, Amelia Licari, Lucia Liotti, Carla Mastrorilli, Domenico Minasi, Francesca Mori, Iria Neri, Aurelia Pantaleo, Francesca Saretta, Carlo Filippo Tesi, Giovanni Corsello, Gian Luigi Marseglia, Alberto Villani, Fabio Cardinale

Abstract

The aim of this guidance is to provide recommendations to clinicians and other interested parties on chronic urticaria in children.

September 19, 2019

Serum IL-1β can be a biomarker in children with severe persistent allergic rhinitis


Abstract
Background
Allergic rhinitis (AR) is one of the most common diseases globally and usually persists throughout life. In the present study, we aimed to determine whether the expression of inflammatory biomarkers has a relationship with the severity of allergic rhinitis and with comorbid asthma or other allergic diseases in children.

September 16, 2019

Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests

Abstract
Background
Cytokines, chemokines, adipocytokines, soluble cell receptors, and immune activation markers play an important role in immune responsiveness and can provide prognostic value since they reflect underlying conditions and disease states. This study was undertaken to investigate the components of biological variation for various laboratory tests of blood immunological biomarkers.